Alpha DNA Investment Management LLC Invests $147,000 in Crocs, Inc. (NASDAQ:CROX)


Share on StockTwits

Alpha DNA Investment Management LLC acquired a new position in Crocs, Inc. (NASDAQ:CROX) in the fourth quarter, Holdings Channel reports. The fund acquired 2,349 shares of the textile maker’s stock, valued at approximately $147,000.

Several other institutional investors have also recently modified their holdings of the company. Nisa Investment Advisors LLC increased its holdings in Crocs by 14.8% in the 4th quarter. Nisa Investment Advisors LLC now owns 2,710 shares of the textile maker’s stock worth $170,000 after buying an additional 350 shares during the period. California State Teachers Retirement System increased its stake in Crocs by 0.4% during the third quarter. California State Teachers Retirement System now owns 101,079 shares of the textile maker’s stock worth $4,319,000 after purchasing an additional 404 shares during the period. JPMorgan Chase & Co. increased its holdings in Crocs by 0.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 63,004 shares of the textile maker’s stock worth $2,642,000 after purchasing an additional 425 shares during the period. Tsfg LLC purchased a new position in Crocs in the fourth quarter valued at $31,000. Finally, Vantage Consulting Group Inc acquired a new position in shares of Crocs in the 4th quarter valued at $33,000. 95.34% of the stock is currently owned by hedge funds and other institutional investors.

In other Crocs news, Director Ian Bickley sold 10,000 shares of the company’s stock in a transaction on Tuesday, March 16th. The stock was sold at an average price of $82.31, for a total value of $823,100.00. Following the transaction, the director now owns 62,116 shares of the company’s stock, valued at $5,112,767.96. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CFO Anne Mehlman sold 11,016 shares of Crocs stock in a transaction on Monday, March 15th. The stock was sold at an average price of $82.21, for a total value of $905,625.36. Following the completion of the transaction, the chief financial officer now owns 131,179 shares in the company, valued at $10,784,225.59. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 95,916 shares of company stock worth $7,459,015. 2.32% of the stock is owned by corporate insiders.

Shares of CROX opened at $81.73 on Thursday. The firm has a market capitalization of $5.35 billion, a PE ratio of 37.32, a P/E/G ratio of 1.35 and a beta of 1.77. The company has a quick ratio of 1.07, a current ratio of 1.70 and a debt-to-equity ratio of 0.59. The firm has a 50-day moving average price of $78.95 and a 200 day moving average price of $65.52. Crocs, Inc. has a 52-week low of $18.11 and a 52-week high of $86.40.

Crocs (NASDAQ:CROX) last posted its quarterly earnings data on Monday, February 22nd. The textile maker reported $1.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.79 by $0.27. The business had revenue of $411.50 million during the quarter, compared to analysts’ expectations of $408.71 million. Crocs had a net margin of 12.08% and a return on equity of 102.93%. The business’s revenue was up 56.5% on a year-over-year basis. During the same period last year, the firm posted $0.12 earnings per share. On average, equities analysts expect that Crocs, Inc. will post 2.93 EPS for the current year.

A number of brokerages have weighed in on CROX. Pivotal Research lifted their price objective on Crocs from $92.00 to $100.00 and gave the company a “buy” rating in a report on Wednesday, March 3rd. Piper Sandler raised their target price on shares of Crocs from $71.00 to $90.00 and gave the stock an “overweight” rating in a research report on Tuesday, January 12th. UBS Group raised their target price on shares of Crocs from $75.00 to $85.00 and gave the stock a “neutral” rating in a research report on Wednesday, February 17th. They noted that the move was a valuation call. Loop Capital raised their target price on shares of Crocs from $75.00 to $90.00 in a research note on Tuesday, January 19th. Finally, Monness Crespi & Hardt upped their target price on shares of Crocs from $60.00 to $91.00 and gave the company a “buy” rating in a research note on Wednesday, January 13th. Three research analysts have rated the stock with a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the stock. The company has a consensus rating of “Buy” and a consensus price target of $78.70.

Crocs Company Profile

Crocs, Inc, together with its subsidiaries, designs, develops, manufactures, markets, and distributes casual lifestyle footwear and accessories for men, women, and children. It offers various footwear products, including sandals, wedges, flips, slides clogs, charms, and shoes under the Crocs brand name.

Recommended Story: Green Investing

Want to see what other hedge funds are holding CROX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Crocs, Inc. (NASDAQ:CROX).

Institutional Ownership by Quarter for Crocs (NASDAQ:CROX)

Receive News & Ratings for Crocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crocs and related companies with MarketBeat.com's FREE daily email newsletter.